Loading company
Loading
Open Financials GOLDENWELL BIOTECH, INC. (GWLL) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $55 | $139 | -60.4% | 10-K 2026-07-01 · proof |
| Gross profit | $12 | $64 | -81.3% | 10-K 2026-07-01 · proof |
| Operating income | -$113,326 | -$123,098 | 10-K 2026-07-01 · proof | |
| Net income | -$296,471 | -$131,498 | 10-K 2026-07-01 · proof | |
| Cash from operating activities | -$22,629 | -$123,077 | 10-K 2026-07-01 · proof | |
| Total assets | $36,120 | $224,192 | -83.9% | 10-K 2026-07-01 · proof |
| Total liabilities | $379,833 | $271,433 | +39.9% | 10-K 2026-07-01 · proof |
| Cash and cash equivalents | $26,775 | $49,404 | -45.8% | 10-K 2026-07-01 · proof |
- What was GOLDENWELL BIOTECH, INC. (GWLL)'s revenue in fiscal 2025?
- GOLDENWELL BIOTECH, INC. (GWLL) reported revenue of $55 for fiscal 2025 (the year ended Dec 31, 2025), against $139 the year before (-60.4%). Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What was GOLDENWELL BIOTECH, INC. (GWLL)'s gross profit in fiscal 2025?
- GOLDENWELL BIOTECH, INC. (GWLL) reported gross profit of $12 for fiscal 2025 (the year ended Dec 31, 2025), against $64 the year before (-81.3%). Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What was GOLDENWELL BIOTECH, INC. (GWLL)'s operating income in fiscal 2025?
- GOLDENWELL BIOTECH, INC. (GWLL) reported operating income of -$113,326 for fiscal 2025 (the year ended Dec 31, 2025), against -$123,098 the year before. Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What was GOLDENWELL BIOTECH, INC. (GWLL)'s net income in fiscal 2025?
- GOLDENWELL BIOTECH, INC. (GWLL) reported net income of -$296,471 for fiscal 2025 (the year ended Dec 31, 2025), against -$131,498 the year before. Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What was GOLDENWELL BIOTECH, INC. (GWLL)'s cash from operating activities in fiscal 2025?
- GOLDENWELL BIOTECH, INC. (GWLL) reported cash from operating activities of -$22,629 for fiscal 2025 (the year ended Dec 31, 2025), against -$123,077 the year before. Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What are GOLDENWELL BIOTECH, INC. (GWLL)'s total assets?
- As of Dec 31, 2025, GOLDENWELL BIOTECH, INC. (GWLL) reported total assets of $36,120, against $224,192 a year earlier (-83.9%). Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What are GOLDENWELL BIOTECH, INC. (GWLL)'s total liabilities?
- As of Dec 31, 2025, GOLDENWELL BIOTECH, INC. (GWLL) reported total liabilities of $379,833, against $271,433 a year earlier (+39.9%). Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
- What are GOLDENWELL BIOTECH, INC. (GWLL)'s cash and cash equivalents?
- As of Dec 31, 2025, GOLDENWELL BIOTECH, INC. (GWLL) reported cash and cash equivalents of $26,775, against $49,404 a year earlier (-45.8%). Source: the 10-K filed with the SEC on Jul 1, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GWLL&period_type=annual&limit=5"Information only, not investment advice.